Potentially reduced-risk products

We’re transforming tobacco with a choice of products

Our growing range of potentially reduced-risk products includes our Next Generation Products, such as vapour and tobacco heating products, and our oral tobacco and nicotine products.

It is widely acknowledged that most of the harm associated with conventional cigarettes is caused by the toxicants in the smoke produced by the burning of tobacco.

Since 2012, we have invested approximately US$2.5 billion in the development and commercialisation of NGPs.

That is why we are dedicated to the development and commercialisation of alternative tobacco and nicotine products that don’t burn tobacco to deliver nicotine to the user.

Our portfolio of potentially reduced-risk products within our Strategic Portfolio now comprises two main product categories:

  • Next Generation Products (NGPs), comprising:
    • Tobacco heating products
    • Vapour products
  • Oral tobacco and nicotine products, including moist snuff and snus.

Since 2012, we have invested approximately US$2.5 billion in the development and commercialisation of NGPs.

We’re setting ourselves ambitious, but achievable aims: by the end of 2018, our objective is to generate over £1 billion in revenue from NGPs and, by 2022, to have increased that figure fivefold to £5 billion.

We’re already making good progress in our two main NGP categories (vapour and tobacco heating products), and in the oral tobacco and nicotine product category.

NGPs – vapour products

Vapour productFollowing our acquisition of Reynolds American Inc. in 2017, we are now the world’s leading vapour company.

Vype, our flagship vapour brand, is now present in most major vaping products markets. We launched our first Vype product in 2013 and today our range provides a choice of different types of vaping systems.

In the US, R.J. Reynolds Vapor Company was formed in 2012 and now offers market-leading Vuse digital vapour products.

Find out more about Vapour products.

NGPs – tobacco heating products

Tobacco heating productOur flagship tobacco heating product – glo – was designed in the UK through a process that involved more than 100 experts across five continents, including scientists, engineers, product designers, tobacco specialists and toxicologists.

We launched glo in Japan in December 2016 and we’re pleased with the progress it’s made since then and in its other launch markets.

We also have glo iFuse, a hybrid electronic device which combines tobacco heating and vaping technology and is available in Romania.

Find out more about Tobacco heating products.

Oral tobacco and nicotine products

Oral tobaccoWe have long sold snus in Sweden and Norway, but following the acquisition of Reynolds American Inc. in July 2017, we significantly increased the size of our oral tobacco and nicotine products range with the addition of leading snus and moist snuff brands in the U.S.

Find out more about Oral tobacco and nicotine products.

Product pipeline

We’re making good progress, but this is just the beginning. Our research and development, led by many hundreds of scientists across the world, is predominately focused on our exciting pipeline of potentially reduced-risk products for the next five years.

External links